Showing 1–4 of 4 results
-
Research | | Open
Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer
- Martin H. Voss
- , Michael S. Gordon
- , Monica Mita
- , Brian Rini
- , Vicky Makker
- , Teresa Macarulla
- , David C. Smith
- , Andrés Cervantes
- , Igor Puzanov
- , Roberto Pili
- , Ding Wang
- , Shadia Jalal
- , Shubham Pant
- , Manish R. Patel
- , Rachel l. Neuwirth
- , Aaron Enke
- , Yaping Shou
- , Farhad Sedarati
- , Douglas V. Faller
- & Howard A. Burris III
-
Research |
-
Research | | Open
Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes
- Chanthirika Ragulan
- , Katherine Eason
- , Elisa Fontana
- , Gift Nyamundanda
- , Noelia Tarazona
- , Yatish Patil
- , Pawan Poudel
- , Rita T. Lawlor
- , Maguy Del Rio
- , Si-Lin Koo
- , Wah-Siew Tan
- , Francesco Sclafani
- , Ruwaida Begum
- , Larissa S. Teixeira Mendes
- , Pierre Martineau
- , Aldo Scarpa
- , Andrés Cervantes
- , Iain Beehuat Tan
- , David Cunningham
- & Anguraj Sadanandam
-
Research | | Open
